1Kim JG, Graham DY. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group. Am J Gastroenterol,1994, 89: 203-207.
2Laheij RJ, Jansen JB, Verbeek AL. Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease. Aliment Pharmacol Ther, 2001,15: 1055-1059.
3Rybar I, Masaryk P, Mateicka F. Nonsteroidal anti-inflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori. Int J Pharmacol Res, 2001,21: 119-125.
4Voutilainen M, Mantynen T, Farkkila M. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol,2001, 36: 817-821.
5Bazzoli F, De Luca L, Graham DY. Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol , 2001,15: 775-785.
6Graham DY. Critical effect of Helicobacter pylori infection on the effectiveness of omeprozole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter , 2002,7: 1-8.
7Feldman M, Cryer B, Mallat D. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled,double-blind randomized trail. Am J Gastroenterol, 2001,96: 1751-1757.
9Yeomans ND, Garas G, Hawkey CJ. The nonsteroidal antiinflammatory drugs controversy. Gastroenterol Clin North Am, 2000,29: 791-805.
10Bhang CS, Lee HS, Kim SS. Effects of selective cyclooxygenase-2 inhabitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter , 2002,7: 14-21.
2Byron C, Mark F. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal and rectal prostagland in lerels and on mucosal injury in healthy humans[J ]. Gastroenterology, 1999,117,17-25.
3Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK,Wu JC, Lau JY, Hui Y, Lai MS, Chan HL, Sung JJ. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-973.
4Pilotto A, Di Mario F, Franceschi M, Leandro G, Battaglia G,Germana B, Marin R, Valerio G. Pantoprazole versus oneweek Helicobacter pylori eradication therapy for the prevention of acute NSA1D-related gastroduodenal damage in elderly subjects. Aliment Pharmacol Ther 2000;14:1077-1082.
5Taha AS. Non-steroidal anti-inflammatory drug gastropathy and Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1999;31(Suppl 1):S23-S26.
7Rainsford KD. The ever-emerging anti-inflammatories. Have there been any real advances? J Physiol Paris 2001;95:11-19.
8Chan FK. Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Gastroenterol Clin North Am 2001;30:937-952.
9Barr M, Buckley M, O'Morain C. Review article: non-steroidal anti-inflammatory drugs and Helicobacter pylori. Aliment Plmrmacol Ther 2000;14(Suppl 3):43-47.
10Schoenfeld P, Kimmey MB, Scheiman J, Bjorkman D, Laine L.Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications-guidelines for prevention and treatment. Aliment Pharmacol Ther 1999;13:1273-1285.
